Joanne Wuensch
Stock Analyst at Citigroup
(4.14)
# 419
Out of 5,182 analysts
466
Total ratings
58.36%
Success rate
9.52%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED Minimed Group | Initiates: Buy | $23 | $14.01 | +64.17% | 1 | Mar 31, 2026 | |
| JNJ Johnson & Johnson | Maintains: Buy | $250 → $274 | $243.04 | +12.74% | 18 | Mar 11, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $242 → $214 | $116.80 | +83.22% | 23 | Mar 11, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $11 → $9 | $9.53 | -5.56% | 17 | Mar 11, 2026 | |
| PODD Insulet | Maintains: Buy | $345 → $338 | $204.31 | +65.43% | 18 | Mar 11, 2026 | |
| HAE Haemonetics | Maintains: Neutral | $75 → $70 | $56.83 | +23.17% | 12 | Mar 11, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $88 → $84 | $70.35 | +19.40% | 9 | Mar 11, 2026 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $81 → $74 | $58.37 | +26.78% | 9 | Mar 11, 2026 | |
| DXCM DexCom | Maintains: Buy | $77 → $84 | $62.22 | +35.00% | 18 | Mar 11, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $102 → $94 | $62.82 | +49.63% | 37 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $16.68 | +13.91% | 23 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $136 | $102.87 | +32.21% | 24 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $590 | $452.07 | +30.51% | 20 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9.1 → $6.5 | $3.52 | +84.66% | 15 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $88 → $87 | $70.17 | +23.98% | 23 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $92 | $86.85 | +5.93% | 10 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $16.49 | +27.35% | 7 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $98 | $90.89 | +7.82% | 24 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $350 → $374 | $330.36 | +13.21% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $455 → $420 | $331.54 | +26.68% | 15 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $125 | $112.77 | +10.85% | 23 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $101 | $81.05 | +24.61% | 22 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $22 | $18.61 | +18.22% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $86.63 | +29.29% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.33 | +212.03% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $154.51 | +61.80% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $74.56 | -7.46% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $224.09 | -43.33% | 6 | Dec 10, 2018 |
Minimed Group
Mar 31, 2026
Initiates: Buy
Price Target: $23
Current: $14.01
Upside: +64.17%
Johnson & Johnson
Mar 11, 2026
Maintains: Buy
Price Target: $250 → $274
Current: $243.04
Upside: +12.74%
iRhythm Holdings
Mar 11, 2026
Maintains: Buy
Price Target: $242 → $214
Current: $116.80
Upside: +83.22%
Integra LifeSciences Holdings
Mar 11, 2026
Maintains: Sell
Price Target: $11 → $9
Current: $9.53
Upside: -5.56%
Insulet
Mar 11, 2026
Maintains: Buy
Price Target: $345 → $338
Current: $204.31
Upside: +65.43%
Haemonetics
Mar 11, 2026
Maintains: Neutral
Price Target: $75 → $70
Current: $56.83
Upside: +23.17%
GE HealthCare Technologies
Mar 11, 2026
Maintains: Neutral
Price Target: $88 → $84
Current: $70.35
Upside: +19.40%
Establishment Labs Holdings
Mar 11, 2026
Maintains: Neutral
Price Target: $81 → $74
Current: $58.37
Upside: +26.78%
DexCom
Mar 11, 2026
Maintains: Buy
Price Target: $77 → $84
Current: $62.22
Upside: +35.00%
Boston Scientific
Mar 11, 2026
Maintains: Buy
Price Target: $102 → $94
Current: $62.82
Upside: +49.63%
Mar 11, 2026
Maintains: Neutral
Price Target: $21 → $19
Current: $16.68
Upside: +13.91%
Mar 11, 2026
Maintains: Buy
Price Target: $140 → $136
Current: $102.87
Upside: +32.21%
Mar 11, 2026
Upgrades: Buy
Price Target: $590
Current: $452.07
Upside: +30.51%
Mar 6, 2026
Maintains: Neutral
Price Target: $9.1 → $6.5
Current: $3.52
Upside: +84.66%
Mar 6, 2026
Maintains: Neutral
Price Target: $88 → $87
Current: $70.17
Upside: +23.98%
Feb 20, 2026
Maintains: Neutral
Price Target: $75 → $92
Current: $86.85
Upside: +5.93%
Feb 19, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $16.49
Upside: +27.35%
Feb 11, 2026
Maintains: Neutral
Price Target: $94 → $98
Current: $90.89
Upside: +7.82%
Jan 16, 2026
Downgrades: Neutral
Price Target: $350 → $374
Current: $330.36
Upside: +13.21%
Dec 11, 2025
Maintains: Buy
Price Target: $455 → $420
Current: $331.54
Upside: +26.68%
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $112.77
Upside: +10.85%
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $81.05
Upside: +24.61%
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $18.61
Upside: +18.22%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $86.63
Upside: +29.29%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.33
Upside: +212.03%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $154.51
Upside: +61.80%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $74.56
Upside: -7.46%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $224.09
Upside: -43.33%